Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|September 22, 2022
Response to osimertinib plus trametinib in a heavily treated epidermal growth factor receptor (EGFR)-positive NSCLC harboring a rare, acquired rapidly accelerated fibrosarcoma B-type (BRAF) p.D594N mutation: a case reportSixiang Li, Xinqing Lin, Shiyong Sun, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 15, 2013
Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysisChengzhi Zhou, Qun Luo, Yinyin Qing, et al.
Experimental and Therapeutic Medicine|May 1, 2023
Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case reportJiaxi Deng, Xinqing Lin, Haiyi Deng, et al.
Arquivos Brasileiros De Cardiologia|August 20, 2025
Prognostic Value of Troponin to Lymphocyte Ratio in Patients with Immune Checkpoint Inhibitor-associated MyocarditisWanwen Chen, Wenhao Zhang, Caiyin Luo, et al.
Anti-Cancer Drugs|June 26, 2024
First case report of sunvozertinib for the treatment of HER2 exon 20 insertion in lung adenocarcinomaTao Luan, Xinqing Lin, Xiaohong Xie, et al.
Angiogenesis|June 29, 2019
Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung diseaseXiaohong Xie, Bingpeng Guo, Xinqing Lin, et al.
Frontiers in Molecular Biosciences|December 17, 2020
Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung AdenocarcinomaXinqing Lin, Liqiang Wang, Xiaohong Xie, et al.
Thoracic Cancer|April 1, 2019
Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature reviewXinqing Lin, Tingting Lu, Zhanhong Xie, et al.
Journal of Thoracic Disease|July 10, 2024
Analysis of the resistance profile of real-world alectinib first-line therapy in patients with <i>ALK</i> rearrangement-positive advanced non-small cell lung cancer using organoid technology in one case of lung cancerYingbo Xie, Yuxin Zhang, Yongqing Wu, et al.
Cancers|July 29, 2023
Assessing the Optimal Regimen: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Long-Acting Granulocyte Colony-Stimulating Factors in Patients with Breast CancerZhixuan You, Haotian Zhang, Yining Huang, et al.
Pageof 9